強気
$100.19
シナリオ価格
$72.310
+1.367 (+1.89%)終値時点
DocuSign, Inc. provides intelligent agreement management (IAM) platform an eSignature solution, and contract lifecycle management (CLM) solution - allow organizations to increase productivity, accelerate contract review cycles, and transform agreement data into insights and actions. The Company’s IAM platform automates agreement workflows, uncovers actionable insights, and leverages artificial intelligence (AI) capabilities, enabling organizations to create, commit, and manage agreements virtually. Its products include eSignature, CLM, IAM Apps, and Add-on Products. Its Add-on Products include Payments to collect payments along with signed agreements; Identity and standards-based signature for enhanced signer-identification and signatures with digital certification; Notary for remote online notarization; Monitor for advanced analytics; Gen for Salesforce for automated agreement generation within Salesforce, among others.
DocuSign is currently priced at $71.08, with a forward P/E ratio of 15.13, suggesting it is reasonably valued compared to its earnings growth potential. However, the recent insider selling, with a 161.71% increase in selling activity, raises concerns about management's confidence in the stock's future performance. Additionally, the stock has only shown a 2.35% increase over the past year, indicating weak demand and potential risks in long-term commitments from customers. Given these factors, it may be prudent to hold rather than buy at this time.
BofA
$64
2026-09-04
BofA
2026-09-04
目標株価
$64
UBS
$70
2026-09-04
UBS
2026-09-04
目標株価
$70
RBC Capital
$70
2026-09-04
RBC Capital
2026-09-04
目標株価
$70
Morgan Stanley
$75
2026-09-04
Morgan Stanley
2026-09-04
目標株価
$75
Citi
$72
2026-09-04
Citi
2026-09-04
目標株価
$72
シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

Docusign Expands Partnership with Salesforce to Enhance Agreement Management

Docusign Executive Liquidates Shares Amid Growth

Docusign Executive Sells Shares Under Rule 10b5-1 Plan

Investment Analysis and Outlook on Software Stocks

Dreamforce 2026: Rising Debate on AI Safety
DocuSign, Inc. provides intelligent agreement management (IAM) platform an eSignature solution, and contract lifecycle management (CLM) solution - allow organizations to increase productivity, accelerate contract review cycles, and transform agreement data into insights and actions. The Company’s IAM platform automates agreement workflows, uncovers actionable insights, and leverages artificial intelligence (AI) capabilities, enabling organizations to create, commit, and manage agreements virtually. Its products include eSignature, CLM, IAM Apps, and Add-on Products. Its Add-on Products include Payments to collect payments along with signed agreements; Identity and standards-based signature for enhanced signer-identification and signatures with digital certification; Notary for remote online notarization; Monitor for advanced analytics; Gen for Salesforce for automated agreement generation within Salesforce, among others. It operates in the Technology sector (SERVICES-PREPACKAGED SOFTWARE industry).
DocuSign is currently priced at $71.08, with a forward P/E ratio of 15.13, suggesting it is reasonably valued compared to its earnings growth potential. However, the recent insider selling, with a 161.71% increase in selling activity, raises concerns about management's confidence in the stock's future performance. Additionally, the stock has only shown a 2.35% increase over the past year, indicating weak demand and potential risks in long-term commitments from customers. Given these factors, it may be prudent to hold rather than buy at this time.
8 analysts cover DOCU: 5 rate it Buy, 3 Hold and 0 Sell. The average price target is 80.23.

$DOCU DocuSign price target raised to $60 from $55 at Wells Fargo Wells Fargo analyst Michael Turrin raised the firm's price target on DocuSign to $60 from $55 and keeps an Equal Weight rating on the shares. The firm notes DocuSign's Q2 was "relatively down the middle." Wells expects investor questions around normalized growth rates, IAM uplift and FY28 trajectory will persist.
もっと見る本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。